WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early ...
Lecanemab received FDA approval in January after a phase 3 trial showed it slows cognitive decline in early-stage Alzheimer's ...
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease ...
ONE OF THOSE PATIENTS. I WISH IT HAD BEEN HERE LONGER AND WE KNEW MORE ABOUT IT, BUT AT LEAST IT’S SOMETHING TO PLACE YOUR ...
An advisory committee to the U.S. Food and Drug Administration unanimously rejected a drug-and-device combination made by a Boston biotech, which the agency had already rejected twice.
The vote essentially upheld the Food and Drug Administration’s earlier rulings, with some members calling for new clinical ...
The 19-member advisory committee unanimously voted against Intarcia in the review, citing cardiovascular and kidney safety concerns.
A CMS pilot project will test a low-cost way to help families support a suffering loved one. It’s more promising than ...
12:00 AM on Jul 24, 2022 CDT — Updated at 11:27 AM on Sep 20, 2023 CDT If you’re looking for a natural and effective alternative to prescription adderall medication, this guide is for you. The best ...
The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and ...
WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early stages ...
WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early ...
